*Actual product packaging may differ from the image shown.
Ozempic® (Injectable, Brand Name)
Depending on the dose prescribed
$396.00–$846.00
Shop All Treatments
Ozempic (Semaglutide), FDA-Approved Weekly Injection for Blood Sugar and Weight
The physician-prescribed GLP-1 injection trusted by millions, now available through personalized provider care.
Ozempic is an FDA-approved brand-name injectable containing semaglutide, prescribed once weekly to improve blood sugar control in adults with type 2 diabetes, and widely recognized for its significant weight loss effects. It contains the same molecule as Wegovy but at a lower dose, and while it is not FDA-approved specifically for weight loss, it is frequently prescribed for that purpose when clinically appropriate. For patients managing type 2 diabetes alongside excess weight, Ozempic addresses both simultaneously through a single weekly injection.
FDA-approved · Physician-prescribed · Manufactured by Novo Nordisk
Semaglutide (GLP-1 Receptor Agonist): Ozempic activates GLP-1 receptors in the brain and gut, reducing appetite, slowing gastric emptying, and stimulating insulin release in response to meals, while suppressing the glucagon that drives blood sugar up between them. At doses up to 2mg, it produces meaningful improvements in HbA1c alongside clinically significant weight reduction. The titration schedule starts low and increases gradually over several months, which helps minimize side effects.
Best for adults with type 2 diabetes who want to improve blood sugar control and lose weight with a single weekly medication. Also well-suited for patients with cardiovascular disease alongside type 2 diabetes, Ozempic has demonstrated reduced risk of major cardiovascular events in this population.
Not recommended for: individuals with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, those with a history of pancreatitis, pregnant individuals, or anyone already taking another semaglutide-containing product. Your provider will review your complete health history before prescribing.
Ozempic’s safety profile is among the most well-characterized of any GLP-1 medication. The most common side effects are nausea, vomiting, diarrhea, constipation, and stomach discomfort, most pronounced early in treatment and during dose increases, typically improving within a few weeks. Injection site reactions and mild fatigue are also reported. Rare but serious risks include pancreatitis, gallbladder disease, diabetic retinopathy complications (in patients with pre-existing retinopathy), and, based on animal data, a theoretical risk of thyroid tumors not confirmed in humans. Ozempic carries a boxed warning for medullary thyroid carcinoma risk.
¹ 26% lower risk of major cardiovascular events (T2D) Marso SP, Bain SC, Consoli A, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6 trial). New England Journal of Medicine, 2016;375(19):1834-1844. (26% reduction in the primary composite MACE endpoint; HR 0.74.) → NEJM · PubMed
² HbA1c reduced by ~1.4 to 1.8 percentage points Sorli C, Harashima SI, Tsoukas GM, et al. Once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN-1). The Lancet Diabetes & Endocrinology, 2017;5(4):251-260. → PubMed
³ Weight loss as a documented secondary effect (T2D) Pratley RE, Aroda VR, Lingvay I, et al. Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7). The Lancet Diabetes & Endocrinology, 2018;6(4):275-286. (Mean weight loss ~4.5 to 6.5 kg with semaglutide in adults with T2D.) → PubMed
Mechanism reference (not a numbered efficacy claim): Drucker DJ. Cell Metabolism, 2018;27(4):740-756. → PubMed
How it Works With EHRX
The entire process is online. No waiting rooms. Just straightforward, medically guided care.
Step 1
Choose your treatment and complete checkout
You'll receive a confirmation email with next steps.
Step 2
Complete a brief medical consultation
Check your email for a link to a short intake form and link to a virtual consult with a licensed physician.
Step 3
A licensed provider reviews your consultation
If approved, your prescription is written and sent to the pharmacy. If not, you receive a full refund.
Step 4
Your pharmacy ships within 3–5 business days
Your medication is shipped directly to your door in temperature-controlled packaging.
What to know before you start.
Ozempic® (Injectable, Brand Name) is a compounded medication prepared by a licensed pharmacy for individual patient use.
It has not been reviewed by the FDA for safety or efficacy, and is prescribed based on the clinical judgment of a qualified healthcare provider. Compounded drugs are permitted to be prescribed but are not FDA-approved for safety and efficacy.
Clinical Evidence
In the SUSTAIN-6 cardiovascular outcomes trial, Ozempic reduced the risk of major cardiovascular events, including heart attack and stroke, by 26% compared to placebo in adults with type 2 diabetes and high cardiovascular risk. In clinical trials, participants also lost an average of around 4 to 5 kg of body weight over roughly two years at therapeutic doses. (Source: Marso et al., NEJM, 2016)
Frequently Asked Questions
We aim to provide absolute clarity regarding your biological data and personalized wellness protocols.
Both contain semaglutide. Ozempic is FDA-approved for type 2 diabetes management at doses up to 2mg. Wegovy is approved specifically for weight management and cardiovascular risk reduction at 2.4mg. Your provider will determine which is appropriate based on your diagnosis and goals.
Once weekly via a pre-filled auto-injector pen, subcutaneously in the abdomen, thigh, or upper arm. The pen is simple to use and most patients are comfortable with self-injection quickly.
Blood sugar improvements often begin within the first few weeks. Weight loss typically becomes noticeable by months 2-3, with continued progress over 6-12 months.
Ozempic is FDA-approved for type 2 diabetes. Your provider will assess your diagnosis and determine the most appropriate medication for your goals.
Yes, baseline HbA1c and other metabolic markers are typically reviewed before and during treatment to track your response.
You won’t be charged for the provider visit. Your care team will explain and may suggest alternatives suited to your profile.
Ozempic has broad insurance coverage for patients with a type 2 diabetes diagnosis. Coverage for weight loss alone varies by plan.
Yes, at any time before your next shipment, with no long-term commitment required.
Regularly, particularly during titration. HbA1c should be monitored periodically to assess your glycemic response.
Contact your care team. Most GI symptoms improve with time or a slower titration pace. Serious symptoms require prompt medical attention.
The next generation
of weight management.
Dual-incretin metabolic support — personalized to you.
